ARCHIVES

In Congress: Time Running out On Effort To Double Market Exclusivity Term

This article is from The Cancer Letter archive.

Vol. 23 No. 43 | November 7, 1997

Download PDF Visit The Full Archive

Related Articles

Trial Links Potential Biomarkers To Drugs For Lung Cancer, To Help Target Therapies

April 30, 2010

FDA Approves SNDA For Gardasil For Anal Cancer And Precancerous Lesions

January 28, 2011

Immunobiology Ready For Grants; Terry Says; Centers Job Permanent

January 27, 1978

NIH Authorization Set For Another Try; Women’s Cancers Are Targeted

July 10, 1992

BCDDP Follow Up To Cost $1.6 Million annually For Five Years Okayed; Limited To 59,000 Women

November 3, 1978

Meta-Analysis Finds ESA Use In Oncology Associated With Increases In VTE, Mortality.

February 29, 2008